Abstract
Since the advent of large-scale, detailed descriptive cancer genomics studies at the beginning of the century, such as The Cancer Genome Atlas (TCGA), labs around the world have been working to make this data useful. Data like these can be made more useful by comparison with complementary functional genomic data. One new example is the application of CRISPR/Cas9-based library screening for cancer-related traits in cell lines. Such screens can reveal genome-wide suppressors of tumorigenesis and metastasis. Here we describe the use of widely available lentiviral libraries for such screens in cultured cell lines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sorek R, Kunin V, Hugenholtz P (2008) CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat Rev Microbiol 6(3):181–186
Wright AV, Nunez JK, Doudna JA (2016) Biology and applications of CRISPR systems: harnessing Nature's toolbox for genome engineering. Cell 164(1–2):29–44
Huang J, Wang Y, Zhao J (2017) CRISPR editing in biological and biomedical investigation. J Cell Physiol
Shalem O, Sanjana NE, Zhang F (2015) High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 16(5):299–311
Shalem O et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84–87
Wang T et al (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343(6166):80–84
Gilbert LA et al (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159(3):647–661
Konermann S et al (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517(7536):583–588
Chow RD et al (2017) AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci 20(10):1329–1341
Song CQ et al (2017) Genome-wide CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice. Gastroenterology 152(5):1161–1173 e1
Munoz DM et al (2016) CRISPR screens provide a comprehensive assessment of Cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions. Cancer Discov 6(8):900–913
Chen S et al (2015) Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160(6):1246–1260
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Slipek, N.J., Varshney, J., Largaespada, D.A. (2019). CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits. In: Starr, T. (eds) Cancer Driver Genes. Methods in Molecular Biology, vol 1907. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8967-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8967-6_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8966-9
Online ISBN: 978-1-4939-8967-6
eBook Packages: Springer Protocols